Tag: Natco

Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn

August 25, 2026 admin

Natco Pharma invests mn in biotech firm eGenesis; total investment at mn

Generic drugmaker Natco Pharma is investing an additional $14 million in U.S.-based biotechnology company eGenesis, which is developing genetically engineered, human-compatible organs for transplantation. The latest investment will be made through convertible promissory notes by Natco Pharma’s subsidiaries. Natco Pharma (Canada) Inc. will invest $9.5 million, while Natco Pharma South Africa Proprietary Ltd will contribute…

Business

Natco Pharma’s Vizag FDF unit gets 4 U.S. FDA observations

August 21, 2026 admin

The U.S. Food and Drug Administration (U.S. FDA) has issued a Form 483 with four observations to Natco Pharma after inspecting the generic drugmaker’s finished dosage formulations (FDF) unit in Visakhapatnam. The U.S. FDA had conducted the inspection from August 17-21. Natco Pharma said it believes the observations are procedural in nature and is confident…

Business

Natco Pharma gets USFDA nod for generic cancer drug, shares rise 4% intra-day

July 20, 2026 admin

Hyderabad-based Indian multinational pharmaceutical and biotechnology company Natco Pharma’s shares were in the spotlight on Monday after it received tentative approval from the U.S. Food and Drug Administration (FDA) for Olaparib, 100 mg, and 150 mg, which are bioequivalent to AstraZeneca Pharmaceuticals’ referenced drug Lynparza used in the treatment of certain types of cancer. The…

Business

U.S. FDA issues warning letter to Natco over facility near Hyderabad

April 9, 2024 admin

Natco Pharma had said at the time that it was confident of addressing all the observations within the stipulated time and working with the U.S. FDA to close them at the earliest. | Photo Credit: Reuters The United States Food and Drug Administration (U.S. FDA) has issued a warning letter to Natco Pharma over quality…

Business